Ken Kersemans

776 total citations
48 papers, 600 citations indexed

About

Ken Kersemans is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Biochemistry. According to data from OpenAlex, Ken Kersemans has authored 48 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Molecular Biology and 16 papers in Biochemistry. Recurrent topics in Ken Kersemans's work include Radiopharmaceutical Chemistry and Applications (19 papers), Amino Acid Enzymes and Metabolism (16 papers) and Medical Imaging Techniques and Applications (11 papers). Ken Kersemans is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (19 papers), Amino Acid Enzymes and Metabolism (16 papers) and Medical Imaging Techniques and Applications (11 papers). Ken Kersemans collaborates with scholars based in Belgium, Germany and United Kingdom. Ken Kersemans's co-authors include Filip De Vos, Veerle Kersemans, Bart Cornelissen, John Mertens, Matthias Bauwens, Christian Vanhove, Kathia De Man, Peter Dubruel, Sandra Van Vlierberghe and Ine Van Nieuwenhove and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Neurochemistry.

In The Last Decade

Ken Kersemans

48 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Kersemans Belgium	15	215	169	135	119	94	48	600
Puja Panwar Hazari India	17	315 1.5×	227 1.3×	75 0.6×	72 0.6×	36 0.4×	70	826
Raunak Varshney India	10	200 0.9×	94 0.6×	51 0.4×	72 0.6×	16 0.2×	39	468
Gopal Pathuri United States	12	72 0.3×	198 1.2×	60 0.4×	91 0.8×	17 0.2×	44	487
Martin Ullrich Germany	17	185 0.9×	248 1.5×	67 0.5×	167 1.4×	8 0.1×	55	835
Jindian Li China	14	119 0.6×	136 0.8×	54 0.4×	96 0.8×	12 0.1×	33	487
Aniruddha Amrite United States	12	265 1.2×	351 2.1×	64 0.5×	26 0.2×	25 0.3×	25	958
Chantal C.M. Appeldoorn Netherlands	16	83 0.4×	550 3.3×	47 0.3×	99 0.8×	23 0.2×	22	976
Izumi O. Umeda Japan	15	176 0.8×	223 1.3×	75 0.6×	90 0.8×	16 0.2×	52	620
Sarah Tam United States	21	314 1.5×	314 1.9×	77 0.6×	240 2.0×	240 2.6×	36	1.5k
Li-Peng Yap United States	10	124 0.6×	229 1.4×	27 0.2×	101 0.8×	42 0.4×	16	460

Countries citing papers authored by Ken Kersemans

Since Specialization

Citations

This map shows the geographic impact of Ken Kersemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Kersemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Kersemans more than expected).

Fields of papers citing papers by Ken Kersemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Kersemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Kersemans. The network helps show where Ken Kersemans may publish in the future.

Co-authorship network of co-authors of Ken Kersemans

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Kersemans. A scholar is included among the top collaborators of Ken Kersemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Kersemans. Ken Kersemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Man, Kathia De, Louke Delrue, Valérie Fonteyne, et al.. (2022). Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging. Molecular Imaging and Biology. 24(5). 750–758. 3 indexed citations

Verhoeven, Jeroen, Benedicte Descamps, Ken Kersemans, et al.. (2021). Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer. Scientific Reports. 11(1). 22623–22623. 15 indexed citations

Verhoeven, Jeroen, Benedicte Descamps, Ken Kersemans, et al.. (2020). Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice. Scientific Reports. 10(1). 21068–21068. 16 indexed citations

Vlierberghe, Sandra Van, Ronald E. Unger, Ken Kersemans, et al.. (2019). Biomimetic strategy towards gelatin coatings on PET. Effect of protocol on coating stability and cell-interactive properties. Journal of Materials Chemistry B. 7(8). 1258–1269. 13 indexed citations

Verhoeven, Jeroen, Fabian Hulpia, Ken Kersemans, et al.. (2019). New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma. Scientific Reports. 9(1). 2878–2878. 22 indexed citations

Man, Kathia De, Yves D’Asseler, Klaus Bacher, et al.. (2019). Radiation Dosimetry and Biodistribution of ¹⁸F-PSMA-11 for PET Imaging of Prostate Cancer. Journal of Nuclear Medicine. 60(12). 1736–1742. 36 indexed citations

Vlieghere, Elly De, Benedicte Descamps, Christian Vanhove, et al.. (2018). Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts. Radiation Oncology. 13(1). 39–39. 23 indexed citations

Kersemans, Ken, et al.. (2018). Automated radiosynthesis of Al[ 18 F]PSMA-11 for large scale routine use. Applied Radiation and Isotopes. 135. 19–27. 33 indexed citations

Neyt, Sara, Ken Kersemans, Jeroen Verhoeven, et al.. (2017). Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice. PLoS ONE. 12(3). e0173529–e0173529. 15 indexed citations

10.

Nieuwenhove, Ine Van, Achim Salamon, Kirsten Peters, et al.. (2016). Gelatin- and starch-based hydrogels. Part A: Hydrogel development, characterization and coating. Carbohydrate Polymers. 152. 129–139. 88 indexed citations

11.

Bauwens, Matthias, Marleen Keyaerts, Tony Lahoutte, et al.. (2010). Preliminary In Vivo Evaluation of [ ¹³¹ I]-2-Iodo- D -Phenylalanine as a Potential Radionuclide Therapeutic Agent in R1M-Fluc Rhabdomyosarcoma Tumor-Bearing NuNu Mice Using Bioluminescent Imaging. Cancer Biotherapy and Radiopharmaceuticals. 25(2). 225–231. 1 indexed citations

12.

Bundel, Dimitri De, Heidi Demaegdt, Tony Lahoutte, et al.. (2009). Involvement of the AT₁receptor subtype in the effects of angiotensin IV and LVV‐haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory. Journal of Neurochemistry. 112(5). 1223–1234. 20 indexed citations

13.

Kersemans, Veerle, Ken Kersemans, & Bart Cornelissen. (2008). Cell Penetrating Peptides for In Vivo Molecular Imaging Applications. Current Pharmaceutical Design. 14(24). 2415–2427. 50 indexed citations

14.

Keyaerts, Marleen, Tony Lahoutte, Bart Neyns, et al.. (2007). 123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients. European Journal of Nuclear Medicine and Molecular Imaging. 34(7). 994–1002. 5 indexed citations

15.

Kersemans, Veerle, Bart Cornelissen, Ken Kersemans, et al.. (2006). 123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice. European Journal of Nuclear Medicine and Molecular Imaging. 33(8). 919–927. 24 indexed citations

16.

Demaegdt, Heidi, Jean‐Paul De Backer, Hilde Laeremans, et al.. (2006). Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme. European Journal of Pharmacology. 546(1-3). 19–27. 29 indexed citations

17.

Kersemans, Veerle, Ken Kersemans, Bart Cornelissen, et al.. (2006). Optimization by Experimental Design of Precursor Synthesis and Radiolabeling of 2-Iodo-L-Phenylalanine, a Novel Amino Acid for Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals. 21(3). 235–242. 1 indexed citations

18.

Kersemans, Veerle, Ken Kersemans, Bart Cornelissen, et al.. (2004). In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.. European Journal of Nuclear Medicine and Molecular Imaging. 31. 1 indexed citations

19.

Kersemans, Ken, et al.. (2004). Synthesis of [18F]-2-fluoromethylphenylalanine, a new potential tracer for tumor specific diagnosis in humans with PET. European Journal of Nuclear Medicine and Molecular Imaging. 31. 1 indexed citations

20.

Lahoutte, Tony, et al.. (2004). Radioiodo-D-2-I-Phenylalanine a new tumour specific tracer for diagnosis and systemic radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 31. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact